Tilray, Inc.

Tilray has fallen sharply over the last month. However, TLRY looks like a good marijuana stock to buy. The stock's forecast looks positive.

Tilray has announced the acquisition of MedMen stake. The forecast for TLRY stock looks positive amid the growing clamor for federal legalization

Tilray was up almost 26 percent on July 28. Why is TLRY stock going up and will it rise more or fall now? Here's what investors can expect.

Tilray stock is rising sharply. How high can TLRY stock go as Reddit traders push for a new short squeeze?

Investors have seen Tilray (TLRY) stock fall sharply from its peak. Will the stock go up and is it a good time to buy?

Tilray stock has attracted retail investors on Reddit’s WallStreetBets forum. What’s TLRY’s stock forecast amid the Reddit chatter?

Marijuana stocks have tumbled from their recent highs. TLRY and APHA are two investment opportunities in the industry now. Which is best?

Investors are swarming to the marijuana sector, and that includes Tilray. Here's why the stock is a buy right now.

The Tilray and Aphria merger has finally been confirmed and will be complete on May 5. What's the forecast for TLRY stock?

On April 30, Tilray shareholders are expected to vote on the merger deal with Aphria. Will TLRY stock rise or fall after the merger date?

Tilray has delayed the merger vote with Aphria. What's happening with the TLRY and APHA merger? Is the merger a done deal?

APHA and TLRY stock have fallen off their highs. As the Tilray and Aphria merger date nears, is there still a merger arbitrage?

While there's some merger arbitrage in the Tilray (TLRY) and Aphria (APHA) merger, investors should buy APHA stock instead of TLRY.

What’s the TLRY-APHA merger date? Is there still an arbitrage opportunity available before the merger is complete?

Tilray's (TLRY) stock forecast is quite bearish in 2021. However, investors have defied Wall Street's bearishness and pushed the stock higher.

Tilray stock has been rising since President Biden won the election. Is Tilray a good marijuana stock to buy in 2021? What can investors expect?

Cannabis investors are looking ahead to the Georgia Senate runoff. Is Tilray stock a buy or a sell amid marijuana uncertainty in 2021?

So far in 2020, Tilray stock has fallen 54 percent. Is the stock a buy or sell at this price? How's the company's outlook?

The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

Marijuana legalization is gathering steam as one of the key topics for the 2020 presidential election. Marijuana is still a federally controlled substance.

In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.

Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.

Marijuana legalization is an ongoing issue in the US. Currently, the District of Columbia and 11 states have legalized cannabis. Marijuana is still illegal for recreational use in Minnesota. However, the state’s voters might favor legalization. Minnesota voters are ready for marijuana legalization Minnesota hasn’t been able to come up with a legalization decision yet. […]

Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.

New Hampshire legalized medical cannabis, but using cannabis for recreational purposes is still prohibited. The state legalized medical marijuana in 2013.

A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]

As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

On January 9, Constellation Brands (STZ) reported its third-quarter results before the market opened. The third quarter ended on November 30.

Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown.

Aurora Cannabis (NYSE:ACB) reported its third-quarter results on May 14. The earnings report was a surprise for most analysts and investors.

Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive.

Aurora Cannabis announced its plan to raise capital and strengthen its liquidity position through a reverse stock split amid the financial crisis.

Marijuana is gaining a lot of attention amid the coronavirus pandemic. Many people think that Joe Biden should support marijuana legalization.

The Tennessee Senate passed a medical marijuana bill due to the rising benefits of medical marijuana. However, the bill includes a poison pill.

Due to rising financial constraints, US cannabis companies are seeking bankruptcy protection from Canada. In the US, marijuana still isn’t legal at the federal level.

Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

Recently, Tilray said it was expanding its footprint to Israel. The company exported its first commercial medical cannabis shipment to Israel last week.

Aurora Cannabis (ACB) (ACB.TO) is a Canadian cannabis giant, but the company’s plans to enter the US market keep getting delayed.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.

Legal cannabis in Mexico is going through several twists and turns. The country first allowed medical marijuana in June 2017.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

Canopy Growth (WEED) (CGC) stock has been under pressure since it reported its earnings for the first quarter of fiscal 2020 on August 14.

HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

Aurora Cannabis (ACB) was trading lower early this morning after falling about 8% last week. It has Aurora completed its Hempco Food and Fiber acquisition.